Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study

Area of Science:

• Pediatric Dermatology
• Wound Care Management
• Pharmacology

Background:

• Itching (pruritus) is a common and distressing symptom during wound healing.
• Conventional treatments like chlorpheniramine and trimeprazine may be insufficient for managing wound-related pruritus in children.
• Persistent itching can lead to wound rubbing, increasing infection risk and impairing healing.

Purpose of the Study:

• To evaluate the efficacy of gabapentin in alleviating itching in pediatric patients with wounds.
• To assess gabapentin as an adjunctive therapy for refractory pruritus in wound healing.

Main Methods:

• A cohort of 35 children experiencing significant itching during wound healing was studied.
• Participants had previously failed to achieve adequate relief with chlorpheniramine and trimeprazine.
• Gabapentin treatment was initiated, and outcomes were assessed within 24 hours.

Main Results:

• All 35 children experienced significant improvement in itching within 24 hours of starting gabapentin.
• Gabapentin demonstrated rapid and effective relief from pruritus associated with wound healing.
• The medication was well-tolerated in this pediatric cohort.

Conclusions:

• Gabapentin is a promising therapeutic option for managing severe itching in pediatric wound healing.
• It offers a valuable alternative for children whose pruritus is unresponsive to standard antihistamines.
• Further research could explore optimal dosing and long-term effects of gabapentin in this population.